The Bellamy's share price is up 42% in March

The Bellamy's Australia Ltd (ASX:BAL) share price has been a strong performer again on Friday. This has stretched its month to date return to 42%…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bellamy's Australia Ltd (ASX: BAL) share price is having another sensational day on the market.

In early afternoon trade the organic infant formula and baby food company's shares are up almost 8% to $11.59.

This gain means the Bellamy's share price has rocketed a massive 42% since the start of the month.

Why is the Bellamy's share price surging higher again?

With no news out of the company, today's gain is a bit of a mystery. But there are a number of potential catalysts that could be behind the move.

One is a reduction in the company's short interest level. Short sellers have successfully targeted Bellamy's over the last 12 months but appear to be moving onto new opportunities now.

ASIC's latest short position report shows that Bellamy's short interest had fallen to 9.3% as of March 8. That was down from 10.3% a day earlier and its lowest level since January. When short sellers close positions they need to buy shares to do so, which could explain the increased demand on the buy side.

Another potential catalyst could be speculation that the company is on the brink of receiving its SAMR accreditation which will allow the company to sell its Chinese-labelled products on mainland China.

Bellamy's has been waiting for SAMR accreditation since the end of 2017, meaning it has been unable to benefit fully from the growing demand for infant formula in the country like rival A2 Milk Company Ltd (ASX: A2M).

The reason investors appear to believe that it could be granted soon is likely to be down to the company launching its high impact campaign in China this month. This campaign will be supported by A-grade ambassadors and key opinion leaders including Stefanie Sun, Zilin Zhang, and Niangao Mama. These three ambassadors have a combined following of over 55 million on Chinese social media platforms.

Should you invest?

Whilst I think Bellamy's could be a good long-term option for patient investors, I would suggest you wait for a better entry point.

A note out of Citi late last month reveals that it expects the company to achieve earnings per share of 38.1 cents in FY 2020. This means that Bellamy's shares are currently changing hands at 30x estimated FY 2020 earnings, which I think is looking a bit stretched.

As a comparison, Citi expects earnings per share of approximately 50 cents from a2 Milk Company in FY 2020, meaning its shares are priced at 26x estimated FY 2020 at present.

Based on this, I see more value in a2 Milk Company's shares at this point in time.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Market News

Why Aeris Resources, Netwealth, Nova Minerals, and Paragon Care shares are dropping today

These shares are under pressure on Friday. Let's find out why.

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Share Market News

Downer EDI wins $870m NZ highway maintenance contracts: What investors need to know

Downer EDI wins major New Zealand state highway maintenance contracts worth NZ$870 million, expanding its infrastructure portfolio.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Broker Notes

Ord Minnett names 2 ASX 200 shares to buy for massive returns

The broker sees a lot of value in these big names. Here's what it is recommending.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »